Ledger.Open graph →
SEC Form D · filed July 21, 2017

Aspyrian Therapeutics, Inc

Offering
$19.0M
Sold
$15.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Alan Tooker · Grand Cayman, Cayman IslandsExec · DirectorAntony Abbiati · Boston, MADirectorGabe Finke · Denver, COExec · DirectorDamian Juric · Grand Cayman, Cayman IslandsDirectorTrey Stewart · Franklin, TNDirectorLarry Lukis · DEERFIELD, MADirectorAndrew Seddon · DEERFIELD, MAExec · DirectorMark Kalinich · Cambridge, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗